Recombinant Human FREQ Protein，GST

FREQ, or Fumarate and Succinate Dehydrogenase-Related Protein, is a crucial protein implicated in the regulation of energy metabolism and cellular signaling pathways. Recent studies have highlighted its potential role in various diseases, including cancer and metabolic disorders. Research into the FREQ protein has gained momentum due to its involvement in the metabolic response to hypoxia and its interactions with key regulatory genes. Alterations in FREQ expression can lead to significant changes in cellular homeostasis, emphasizing its importance in physiological processes. Moreover, understanding the reorganization of FREQ plays a vital role in deciphering the underlying mechanisms of tumorigenesis and the progression of metabolic diseases. This has prompted scientists to explore the structure, function, and regulatory networks associated with FREQ, paving the way for potential therapeutic interventions. Insights gained from this research may lead to novel strategies to manipulate FREQ activity, ultimately contributing to the development of targeted therapies for conditions characterized by dysregulated energy metabolism.